| 5.7 -0.2 (-3.39%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.12 | 1-year : | 8.32 |
| Resists | First : | 6.09 | Second : | 7.12 |
| Pivot price | 5.65  |
|||
| Supports | First : | 5.33 | Second : | 4.85 |
| MAs | MA(5) : | 5.9  |
MA(20) : | 5.51 |
| MA(100) : | 5.26 |
MA(250) : | 4.99 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 78.5 |
D(3) : | 84.5 |
| RSI | RSI(14): 53.6 |
|||
| 52-week | High : | 6.5 | Low : | 3.84 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SRTA ] has closed below upper band by 46.8%. Bollinger Bands are 48.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 5.91 - 5.94 | 5.94 - 5.97 |
| Low: | 5.57 - 5.62 | 5.62 - 5.66 |
| Close: | 5.63 - 5.7 | 5.7 - 5.76 |
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.
Thu, 13 Aug 2026
Strata critical medical director Reginald Love disposes of $29,273 in stock - Investing.com
Thu, 13 Aug 2026
Strata Critical Medical (SRTA) director Reginald Love sells 5,091 shares at $5.75 - stocktitan.net
Tue, 11 Aug 2026
Immersion Investment Views Strata Critical Medical (SRTA) as a “Babushka Doll” - Yahoo Finance
Fri, 07 Aug 2026
Analysts Are Updating Their Strata Critical Medical, Inc. (NASDAQ:SRTA) Estimates After Its Second-Quarter Results - simplywall.st
Thu, 06 Aug 2026
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Wed, 05 Aug 2026
Strata Critical Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SRTA) 2026-08-05 - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 88 (M) |
| Shares Float | 63 (M) |
| Held by Insiders | 14.2 (%) |
| Held by Institutions | 68.9 (%) |
| Shares Short | 4,330 (K) |
| Shares Short P.Month | 7,820 (K) |
| EPS | -0.29 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.22 |
| Profit Margin | 15.7 % |
| Operating Margin | -6.4 % |
| Return on Assets (ttm) | -1.9 % |
| Return on Equity (ttm) | -9.3 % |
| Qtrly Rev. Growth | 60.7 % |
| Gross Profit (p.s.) | 0.61 |
| Sales Per Share | 2.89 |
| EBITDA (p.s.) | 0.08 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -36 (M) |
| Levered Free Cash Flow | -20 (M) |
| PE Ratio | -20.36 |
| PEG Ratio | 0 |
| Price to Book value | 1.77 |
| Price to Sales | 1.96 |
| Price to Cash Flow | -14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|